LSE - Delayed Quote GBp
Beximco Pharmaceuticals Limited (BXP.L)
40.00
+2.00
+(5.26%)
At close: April 23 at 12:54:39 PM GMT+1
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
--
8,364,466.32
6,084,786.86
5,214,176.45
6,023,263.96
Operating Cash Flow
6,631,525.32
8,364,466.32
6,084,786.86
5,214,176.45
--
Investing Cash Flow
-3,132,965.61
-2,406,458.61
-2,617,017.63
-7,680,054.42
-2,524,645.85
Financing Cash Flow
-2,951,411.54
-6,259,873.54
-3,560,570.81
2,615,225.20
-3,458,168.02
End Cash Position
1,642,961.17
854,105.65
1,135,686.18
1,168,673.82
675,466.61
Capital Expenditure
-2,727,966.32
-2,234,557.32
-2,710,027.66
-2,939,497.99
-2,558,417.72
Free Cash Flow
3,903,558.99
6,129,908.99
3,374,759.20
2,274,678.46
3,464,846.24
6/30/2021 - 10/21/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade